Clearmind Medicine (CMND) Interest Coverage Ratio (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Interest Coverage Ratio of 3.05 for Q2 2026, up 99.58% year-over-year from 1.53 in Q2 2025, and up 95.95% quarter-over-quarter from 75.3 in Q1 2026.
Clearmind Medicine (CMND) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Clearmind Medicine's Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 3.05 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio rose 99.58% year-over-year to 3.05; the TTM figure through Apr 2026 stood at 9.44 (up 98.85% YoY), while the FY2025 annual figure was 17.44, up 98.21% from the prior year.
- Interest Coverage Ratio for Q2 2026 stood at 3.05, up from 75.3 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 1.0 in Q3 2022, with the low at 1166299.0 in Q1 2024.
- The 5-year median for Interest Coverage Ratio is 723.17 (2025), against an average of 78373.48.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio plunged 258620.19% in 2023, then surged 99.93% in 2025.
- Clearmind Medicine's Interest Coverage Ratio stood at 1.0 in 2022, then slumped by 258620.19% to 2584.86 in 2023, then surged by 69.2% to 796.26 in 2024, then surged by 99.66% to 2.67 in 2025, then slipped by 14.14% to 3.05 in 2026.
- Business Quant data shows CMND's Interest Coverage Ratio at 3.05 in Q2 2026, 75.3 in Q1 2026, and 2.67 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -3.05 |
| Jan 31, 2026 | -75.30 |
| Oct 31, 2025 | -2.67 |
| Jul 31, 2025 | -1,495.94 |
| Apr 30, 2025 | -723.17 |
| Jan 31, 2025 | -806.74 |
| Oct 31, 2024 | -796.26 |
| Jul 31, 2024 | -892.82 |
| Apr 30, 2024 | -534.30 |
| Jan 31, 2024 | -1.17 Mn |
| Jul 31, 2023 | -2,584.86 |
| Apr 30, 2023 | -2.98 |
| Jan 31, 2023 | -1,063.69 |
| Jul 31, 2022 | 1.00 |
| Jan 31, 2022 | -322.47 |